Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy Chuchu Zhao et al, 2018, Arch Gynecol Obstet CrossRef
When biomarkers define a drug indication Jan Trøst Jørgensen, 2018, Expert Review of Molecular Diagnostics CrossRef
The clinicopathological features and prognosis of tumor MSI in East Asian colorectal cancer patients using NCI panel Jianmin Zheng et al, 2018, Future Oncology CrossRef
Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China Xiangyan Zhang et al, 2018 CrossRef
Molecular classification and precision therapy of cancer: immune checkpoint inhibitors Yingyan Yu, 2018, Front. Med. CrossRef
Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease Michael M. Boyiadzis et al, 2018, j. immunotherapy cancer CrossRef
Use of immunohistochemical versus microsatellite analyses as markers for colorectal cancer Utku Tantoğlu et al, 2018 CrossRef
Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions Luis V. Syro et al, 2018, Front. Endocrinol. CrossRef
MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications Ashlee M. Strubberg et al, 2017, Dis. Model. Mech. CrossRef
Anomalies de la réparation de l’ADN et cancers gynécologiques Aurélie Auguste et al, 2017, Bulletin du Cancer CrossRef
Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond Hui-li Wong et al, 2018, Future Oncology CrossRef
Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma Gianluca Lopez et al, 2018, IJMS CrossRef
Identification of Lynch syndrome risk variants in the Romanian population Paul D. Iordache et al, 2018, J Cell Mol Med CrossRef
Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers Vanessa L. Hale et al, 2018, Genome Med CrossRef
Architects meets Repairers: The interplay between homeobox genes and DNA repair Bruno César Feltes, 2018, DNA Repair CrossRef
Épidémiologie des tumeurs MSI : fréquence des tumeurs MSI en fonction de la localisation du cancer et de son stade Raphaël Colle et al, 2018, Bulletin du Cancer CrossRef
Microsatellite instability test using peptide nucleic acid probe-mediated melting point analysis: a comparison study Mi Jang et al, 2018, BMC Cancer CrossRef
Mismatch Repair Protein Loss as a Prognostic and Predictive Biomarker in Breast Cancers Regardless of Microsatellite Instability Nicola Fusco et al, 2018 CrossRef
Advances in the Study of Microsatellite Instability and Clinical and Prognosis of Gastric Cancer 颖晨 史, 2019, ACRPO CrossRef
Clinical implications of the genetics of sporadic colorectal cancer Jesse Fischer et al, 2019, ANZ Journal of Surgery CrossRef
Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort Daniel Bengtsson et al, 2017 CrossRef
Identification of recurrent mutational events in anorectal melanoma Hui Min Yang et al, 2017, Mod Pathol CrossRef
Immune check-point in endometrial cancer Francesca De Felice et al, 2019, Int J Clin Oncol CrossRef
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach C Luchini et al, 2019 CrossRef
Pembrolizumab in advanced gastrointestinal malignancies with defective dna mismatch repair: A case series DavidD Stenehjem et al, 2018, J Immunother Precis Oncol CrossRef
Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer null Eriksson et al, 2019, JCM CrossRef
Mikrosatelliteninstabilität W. Dietmaier et al, 2019, Pathologe CrossRef
An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome Manon Suerink et al, 2019, Genet Med CrossRef
Number of Intratumoral T Lymphocytes Is Associated With Lymph Node Size, Lymph Node Harvest, and Outcome in Node-Negative Colon Cancer Bruno Märkl et al, 2016, Am J Clin Pathol CrossRef
DNA damage response as a therapeutic target in gynecological cancers Alexandra Leary et al, 2016, Current Opinion in Oncology CrossRef
Microsatellite instability in melanoma Ondřej Kubeček et al, 2016, Melanoma Research CrossRef
Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence? João Lobo et al, 2017, Virchows Arch CrossRef
Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy? Giuseppe Palmieri et al, 2017, J Transl Med CrossRef
Molecular Profiling in Colon Cancer: Where Are We Now? Roberto S. Fratamico et al, 2017, Curr Colorectal Cancer Rep CrossRef
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine Laetitia Nebot-Bral et al, 2017, European Journal of Cancer CrossRef
Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma R. J. Head et al, 2017, Cancer Biology & Therapy CrossRef
Classification of Endometrial Carcinoma Mohammed Akhtar et al, 2019, Advances In Anatomic Pathology CrossRef
A Pediatric Case of Glioblastoma Multiforme Associated With a Novel Germline p.His112CysfsTer9 Mutation in the MLH1 Gene Accompanied by a p.Arg283Cys Mutation in the TP53 Gene: A Case Report Aleksandra Stajkovska et al, 2019, Front. Genet. CrossRef
Microsatellite instability screening in colorectal adenomas to detect Lynch syndrome patients? A systematic review and meta-analysis Parag D. Dabir et al, 2019, Eur J Hum Genet CrossRef
Melanoma and Vitiligo: In Good Company Cristina Maria Failla et al, 2019, IJMS CrossRef
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Sona Vodenkova et al, 2020, Pharmacol Ther CrossRef
Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes Jaclyn F. Hechtman et al, 2019, Mod Pathol CrossRef
Reliable Clinical MLH1 Promoter Hypermethylation Assessment using a High-Throughput Genome-Wide Methylation Array Platform Jamal K. Benhamida et al, 2019, The Journal of Molecular Diagnostics CrossRef
The somatic mutation landscape of the human body Pablo E. García-Nieto et al, 2019, Genome Biol CrossRef
Cell-Selective Cytotoxicity of a Fluorescent Rhodium Metalloinsertor Conjugate Results from Irreversible DNA Damage at Base Pair Mismatches Adela Nano et al, 2020, Biochemistry CrossRef
Tumour characteristics provide evidence for germline mismatch repair missense variant pathogenicity Shuwei Li et al, 2020, J Med Genet CrossRef
Temozolomide therapy for aggressive pituitary tumours – current understanding and future perspectives Pia Burman et al, 2020, Rev Endocr Metab Disord CrossRef
Decoding the Genomic Report for Radiologists Daniel A. Smith et al, 2020, American Journal of Roentgenology CrossRef
A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue. Gašper Klančar et al, 2020, Genes (Basel) CrossRef
Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways Zhiyan Hu et al, 2020, J Exp Clin Cancer Res CrossRef
Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents. Trinayan Kashyap et al, 0 CrossRef
Hypermutation and microsatellite instability in gastrointestinal cancers Kizuki Yuza et al, 2017, Oncotarget CrossRef
Less correlation between mismatch repair proteins deficiency and decreased expression of HLA class I molecules in endometrial carcinoma: a different propensity from colorectal cancer Tasuku Mariya et al, 2020, Med Mol Morphol CrossRef
Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer? Monica Marabelli et al, 2020, Digestive and Liver Disease CrossRef
MLH1 and MSH2 mismatch repair protein profile using immunohistochemistry in Nepalese colorectal cancer patients Matrika Bhattarai et al, 2020, Med J Indones CrossRef
Molecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer Salah A. Sheweita et al, 2020, Mediators of Inflammation CrossRef
Immunohistochemical mismatch repair proteins expression as a tool to predict the melanoma immunotherapy response Giovanni Ponti et al, 2019, mol clin onc CrossRef
Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer Byung Woog Kang et al, 2020, ESMO Open CrossRef
Clinical implications of mismatch repair deficiency screening in patients with mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN) Lei Lou et al, 2020, European Journal of Surgical Oncology CrossRef
The DNA Glycosylase NEIL2 Suppresses Fusobacterium-Infection-Induced Inflammation and DNA Damage in Colonic Epithelial Cells Ibrahim M. Sayed et al, 2020, Cells CrossRef
Colorectal Cancer and Probiotics: Are Bugs Really Drugs? Purushottam Lamichhane et al, 2020, Cancers CrossRef
Cáncer de endometrio en el síndrome de Lynch H. Khider et al, 2020, EMC - Ginecología-Obstetricia CrossRef
Interface of DNA Repair and Metabolism Daniel Marconi et al, 2020, Curr. Tissue Microenviron. Rep. CrossRef
Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP) Shih-Ching Chang et al, 2020, Cancers CrossRef
Evaluating Mismatch Repair/Microsatellite Instability Status Using Cytology Effusion Specimens to Determine Eligibility for Immunotherapy Elizabeth M. Jacobi et al, 2021 CrossRef
DNA-protein biomarkers for immunotherapy in the era of precision oncology Binnari Kim et al, 2021, J Pathol Transl Med CrossRef
Mismatch Repair Status Characterization in Oncologic Pathology: Taking Stock of the Real-World Possibilities Roberto Piciotti et al, 2021, JMP CrossRef
Industrializing engineered autologous T cells as medicines for solid tumours Cedrik M. Britten et al, 2021, Nat Rev Drug Discov CrossRef
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? Giuseppe Palmieri et al, 2021, Front. Oncol. CrossRef
Expression of Mismatch Repair Proteins in Merkel Cell Carcinoma Thilo Gambichler et al, 2021, Cancers CrossRef
Rhodium Complexes Targeting DNA Mismatches as a Basis for New Therapeutics in Cancers Deficient in Mismatch Repair Adela Nano et al, 2021, Biochemistry CrossRef
Immunotherapy in endometrial cancer: rationale, practice and perspectives Wenyu Cao et al, 2021, Biomark Res CrossRef
Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy M. Repetto et al, 2021, European Journal of Cancer CrossRef
Progress and challenges of immunotherapy in triple-negative breast cancer Yinxing Zhu et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
Upregulated NLGN1 predicts poor survival in colorectal cancer Qian Yu et al, 2021, BMC Cancer CrossRef
Endometrial Tumors with MSI-H and dMMR Share a Similar Tumor Immune Microenvironment Yunfeng Song et al, 2021, OTT CrossRef
The prognostic and clinicopathological roles of microsatellite instability, PD-L1 expression and tumor-infiltrating leukocytes in familial adenomatous polyposis Min Shu Ma et al, 2021, European Journal of Surgical Oncology CrossRef
The potentiality of immunotherapy for sarcomas: a summary of potential predictive biomarkers Jin Liang et al, 2020, Future Oncology CrossRef
Mismatch repair deficiency in canine neoplasms Sakuya Inanaga et al, 2021, Vet Pathol CrossRef
YB-1 Oncoprotein Controls PI3K/Akt Pathway by Reducing Pten Protein Level Antonella Delicato et al, 2021, Genes CrossRef
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas Alessandro De Vita et al, 2021, IJMS CrossRef
Genomic instability, inflammatory signaling and response to cancer immunotherapy Mengting Chen et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
Examination of Gene Loss in the DNA Mismatch Repair Pathway and Its Mutational Consequences in a Fungal Phylum Megan A Phillips et al, 2021 CrossRef
Mutation rate and spectrum in obligately outcrossing Caenorhabditis elegans mutation accumulation lines subjected to RNAi-induced knockdown of the mismatch repair gene msh-2
Vaishali Katju et al, 2021 CrossRef
Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma Yuan Li et al, 2021, Insights Imaging CrossRef
Microsatellite Instability Assessment by Immunohistochemistry in Acute Myeloid Leukemia: A Reappraisal and Review of the Literature Siba El Hussein et al, 2021, Clinical Lymphoma Myeloma and Leukemia CrossRef
Recent insights into the use of immune checkpoint inhibitors in gastric cancer Soraia Rodrigues et al, 2022 CrossRef
Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer YuanLin Sun et al, 2022, Front. Cell Dev. Biol. CrossRef
Proficiency Testing to Improve Interobserver Agreement for Mismatch Repair Deficiency Immunohistochemistry: An Invitation to Join CBQA Readout Raul S. Gonzalez et al, 2022 CrossRef
Recent Advances in Therapeutic Application of DNA Damage Response Inhibitors
against Cancer Stina George Fernandes et al, 2022, ACAMC CrossRef
The CtIP-CtBP1/2-HDAC1-AP1 transcriptional complex is required for the transrepression of DNA damage modulators in the pathogenesis of osteosarcoma Xun Chen et al, 2022, Translational Oncology CrossRef
Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers—A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference Karen Mulder et al, 2022, Current Oncology CrossRef
Colorectal cancer immunotherapy-Recent progress and future directions Wen Zhao et al, 2022, Cancer Letters CrossRef
Relationship of microsatellite instability to mismatch repair deficiency in malignant tumors of dogs Sakuya Inanaga et al, 2022, Veterinary Internal Medicne CrossRef
Microsatellite Instability as a Predictor of Outcomes in Colorectal Cancer in the Era of Immune-Checkpoint Inhibitors Csongor György Lengyel, 2021, CDT CrossRef
Marker assessments in
ER‐
positive breast cancers: old markers, new applications?
Joshua J X Li et al, 2022, Histopathology CrossRef
Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients Min Jin et al, 2022, Front. Microbiol. CrossRef
Molecular Pathology of Gastric Cancer Moonsik Kim et al, 2022, J Gastric Cancer CrossRef
Unique genomic and neoepitope landscapes across tumors: a study across time, tissues, and space within a single lynch syndrome patient Tanya N. Phung et al, 2020, Sci Rep CrossRef
Tissue microarrey: a potential cost-effective approach for mismatch repair testing in colorectal cancer Shai Farkash et al, 2022, BMC Gastroenterol CrossRef
An assessment of mismatch repair deficiency in ovarian tumours at a public hospital in Johannesburg, South Africa S R De Klerk et al, 2022, S Afr J Obstet Gynae CrossRef
Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control Kyle Concannon et al, 2023, Molecular Cell CrossRef
Amplicon-based NGS test for assessing MLH1 promoter methylation and its correlation with BRAF mutation in colorectal cancer patients Sara Iolanda Oliveira da Silva et al, 2023, Experimental and Molecular Pathology CrossRef
Primary retroperitoneal nodal endometrioid carcinoma associated with Lynch syndrome: A case report Daniela Fischerova et al, 2023, Front. Oncol. CrossRef
Molecular testing of DNA damage response pathways in prostate cancer patients Lalit Patel et al, 2023 CrossRef
Amplicon Based NGS Test for Assessing MLH1 Promoter Methylation and its Correlation with BRAF Mutation in Colorectal Cancer Patients Sara Iolanda Oliveira da Silva et al, 2022, SSRN Journal CrossRef
Lynch-like syndrome with germline WRN mutation in Bulgarian patient with synchronous endometrial and ovarian cancer Zornitsa Bogomilova Kamburova et al, 2023, Hered Cancer Clin Pract CrossRef
Nivolumab in the treatment of pretreated patients with metastatic colorectal carcinoma with high microsatellite instability Beatric Bencsiková, 2023, Onkologie CrossRef
DNA Repair Deficiency and the Immune Microenvironment: A Pathways Perspective Yuzhen Zhou et al, 2023, DNA Repair CrossRef
Targeted mutation-based therapy for intrahepatic cholangiocarcinoma Facai Yang et al, 2023, Hepatoma Res CrossRef
Current progress of immune checkpoint inhibitors for advanced colorectal cancer: concentrating on the efficacy improvement Yang Changjiang et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
Identification of comprehensive biomarkers in patients with mismatch repair-deficient Colon Adenocarcinoma based on parallel multi-omics Zhengjun Li et al, 2023, Laboratory Investigation CrossRef
Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer Giuseppe Rospo et al, 2024, Genome Med CrossRef
Ring Finger 43 Hot-spot Frameshift Mutation G659V in Colorectal Cancer Patients: Report from a Tertiary Cancer Care Hospital in North India Smreti Vasudevan et al, 2024 CrossRef
High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment Options Yusuke Matoba et al, 2024, Reprod. Sci. CrossRef
Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers Gianmaria Miolo et al, 2024, Diagnostics CrossRef